Form 4 for TECH Bio-Techne
Accepted 2021-08-10 00:00:00 ET · period of report 2021-08-06 · accession 0000914190-21-000216 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-08-10 | 2021-08-09 | TECH | Hippel James | CFO | S - Sale+OE | $478.90 | -10.0K | 10.9K | -48% | -$4.79M |
| D | 2021-08-10 | 2021-08-08 | TECH | Hippel James | CFO | F - Tax | $481.82 | -1,665 | 10.9K | -13% | -$802.2K |
| DM | 2021-08-10 | 2021-08-08+ | TECH | Hippel James | CFO | M - OptEx | $79.65 | +13.4K | 12.5K | New | +$1.07M |
| DM | 2021-08-10 | 2021-08-06 | TECH | Hippel James | CFO | A - Grant | $0.00 | +19.7K | 1,945 | New | $0 |
| DM | 2021-08-10 | 2021-08-08+ | TECH | Hippel James | CFO | M - OptEx | $0.00 | -13.4K | 10.0K | -57% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-09 | S | D | 700 | $480.66 | 11,755 | D | — | — | (F5) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $480.23 to $481.185, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 2 | Common | Common Stock | 2021-08-08 | F | D | 1,665 | $481.82 | 10,855 | D | — | — | |
| 3 | Common | Common Stock | 2021-08-09 | M | A | 10,000 | $106.59 | 20,855 | D | — | — | |
| 4 | Common | Common Stock | 2021-08-09 | S | D | 5,200 | $477.69 | 15,655 | D | — | — | (F1) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $477.20 to $478.13, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 5 | Common | Common Stock | 2021-08-09 | S | D | 1,800 | $478.58 | 13,855 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $478.25 to $479.12, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 6 | Common | Common Stock | 2021-08-09 | S | D | 1,300 | $479.96 | 12,555 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $479.69 to $480.275, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 7 | Common | Common Stock | 2021-08-09 | S | D | 100 | $480.70 | 12,455 | D | — | — | (F4) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $480.70 to $480.70, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 8 | Common | Common Stock | 2021-08-09 | S | D | 300 | $481.61 | 11,455 | D | — | — | (F6) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $481.49 to $481.80, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 9 | Common | Common Stock | 2021-08-09 | S | D | 300 | $483.62 | 11,155 | D | — | — | (F7) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $483.59 to $483.67, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 10 | Common | Common Stock | 2021-08-09 | S | D | 300 | $484.98 | 10,855 | D | — | — | (F8) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $484.64 to $485.4475, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 11 | Common | Common Stock | 2021-08-08 | M | A | 3,383 | $0.00 | 12,520 | D | — | — | |
| 12 | Derivative | Stock Options (Right to Buy) | 2021-08-06 | A | A | 10,134 | $0.00 | 10,134 | D | $481.82 · — to 2028-08-06 | 10,134 Common Stock | (F20) Options to purchase 2,534 shares vest on each of 8/6/2022 and 8/6/2023 and options to purchase 2,533 shares vest on each of 8/6/2024 and 8/6/2025. |
| 13 | Derivative | Stock Options (Right to Buy) | 2021-08-06 | A | A | 7,600 | $0.00 | 7,600 | D | $481.82 · — to 2028-08-06 | 7,600 Common Stock | (F19) Vests in full or in part on 8/6/2024 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). |
| 14 | Derivative | Restricted Stock Units | 2021-08-06 | A | A | 1,945 | $0.00 | 1,945 | D | — · — to — | 1,945 Common Stock | (F9) Each restricted stock unit represents a contingent right to receive one share of Bio-Techne Corporation common stock. (F19) Vests in full or in part on 8/6/2024 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). |
| 15 | Derivative | Restricted Stock Units | 2021-08-08 | M | D | 3,383 | $0.00 | 0 | D | — · — to — | 3,383 Common Stock | (F9) Each restricted stock unit represents a contingent right to receive one share of Bio-Techne Corporation common stock. (F11) Vested in full on 8/8/2021 upon the certification of achievement of performance goals. |
| 16 | Derivative | Stock Options (Right to Buy) | 2021-08-09 | M | D | 10,000 | $0.00 | 10,000 | D | $106.59 · — to 2023-08-18 | 10,000 Common Stock | (F10) Fully exercisable. |